Related references
Note: Only part of the references are listed.Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides
Tetsuro Hikichi et al.
JOURNAL OF HUMAN GENETICS (2022)
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
Rom Leidner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Uniform genomic data analysis in the NCI Genomic Data Commons
Zhenyu Zhang et al.
NATURE COMMUNICATIONS (2021)
Immunogenomics in personalized cancer treatments
Kazuma Kiyotani et al.
JOURNAL OF HUMAN GENETICS (2021)
Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma
Teng Wei et al.
ONCOIMMUNOLOGY (2021)
Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2
Kazuma Kiyotani et al.
JOURNAL OF HUMAN GENETICS (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
Parisa Malekzadeh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Genetic and phenotypic landscape of the major histocompatibilty complex region in the Japanese population
Jun Hirata et al.
NATURE GENETICS (2019)
Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
Winifred Lo et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
Lili Ren et al.
ONCOIMMUNOLOGY (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
Kazuma Kiyotani et al.
CANCER SCIENCE (2018)
Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer
Tatsuo Matsuda et al.
CLINICAL CANCER RESEARCH (2018)
Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells
Taigo Kato et al.
Oncotarget (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Comprehensive analysis of the clinical immuno-oncology landscape
J. Tang et al.
ANNALS OF ONCOLOGY (2018)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation
Matthias Leisegang et al.
CLINICAL CANCER RESEARCH (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder Cancer
Noura J. Choudhury et al.
EUROPEAN UROLOGY FOCUS (2016)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran et al.
SCIENCE (2015)
HLA Micropolymorphisms Strongly Affect Peptide-MHC Multimer-Based Monitoring of Antigen-Specific CD8+ T Cell Responses
Marit M. van Buuren et al.
JOURNAL OF IMMUNOLOGY (2014)
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher et al.
NATURE (2014)
Identification of an HLA-A2-Restricted Epitope Peptide Derived from Hypoxia-Inducible Protein 2 (HIG2)
Sachiko Yoshimura et al.
PLOS ONE (2014)
Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor α and β chains using next-generation sequencing (NGS)
Hua Fang et al.
ONCOIMMUNOLOGY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Targeting mutant fibroblast growth factor receptors in cancer
Heidi Greulich et al.
TRENDS IN MOLECULAR MEDICINE (2011)
HLA class I supertypes: a revised and updated classification
John Sidney et al.
BMC IMMUNOLOGY (2008)
Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette
Matthias Leisegang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire
Anthony Tanoto Tan et al.
JOURNAL OF VIROLOGY (2008)
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11
Claus Lundegaard et al.
NUCLEIC ACIDS RESEARCH (2008)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
Share Paper
